313 related articles for article (PubMed ID: 25895006)
1. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
[TBL] [Abstract][Full Text] [Related]
2. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
3. Blood-based biomarkers can differentiate ulcerative colitis from Crohn's disease and noninflammatory diarrhea.
Burakoff R; Chao S; Perencevich M; Ying J; Friedman S; Makrauer F; Odze R; Khurana H; Liew CC
Inflamm Bowel Dis; 2011 Aug; 17(8):1719-25. PubMed ID: 21744426
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
[TBL] [Abstract][Full Text] [Related]
8. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.
Sipos F; Galamb O; Wichmann B; Krenács T; Tóth K; Leiszter K; Muzes G; Zágoni T; Tulassay Z; Molnár B
Dis Markers; 2011; 30(1):1-17. PubMed ID: 21508504
[TBL] [Abstract][Full Text] [Related]
10. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
Inoue T; Iijima H; Tajiri M; Shinzaki S; Shiraishi E; Hiyama S; Mukai A; Nakajima S; Iwatani H; Nishida T; Mizushima T; Yasui T; Isaka Y; Kanto T; Tsujii M; Miyoshi E; Wada Y; Takehara T
Inflamm Bowel Dis; 2012 Sep; 18(9):1723-34. PubMed ID: 22241690
[TBL] [Abstract][Full Text] [Related]
13. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
[TBL] [Abstract][Full Text] [Related]
14. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT
Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.
Burczynski ME; Peterson RL; Twine NC; Zuberek KA; Brodeur BJ; Casciotti L; Maganti V; Reddy PS; Strahs A; Immermann F; Spinelli W; Schwertschlag U; Slager AM; Cotreau MM; Dorner AJ
J Mol Diagn; 2006 Feb; 8(1):51-61. PubMed ID: 16436634
[TBL] [Abstract][Full Text] [Related]
17. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
[TBL] [Abstract][Full Text] [Related]
18. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
20. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
